GW Pharma (GWPH) Reports Q4 Loss of $0.23/Share

GW Pharma (NASDAQ: GWPH) reported Q4 EPS of ($0.23), versus ($0.18) reported last year. Revenue for the quarter came in at $2.34 million, versus $2.37 million reported last year.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• InspireMD (NSPR) Tops Q2 EPS by 1c